Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Number of holders
-
21
-
Total Principal
-
197M
-
Shares change
-
+4.52M
-
Total reported value, excl. options
-
$329M
-
Value change
-
+$13.1M
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$1.67
Significant Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 has 21 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 197M shares.
Largest 10 shareholders include DEERFIELD MANAGEMENT CO (45M shares), STEELHEAD PARTNERS LLC (38M shares), Citadel Advisors LLC (23.6M shares), WOLVERINE ASSET MANAGEMENT LLC (21.1M shares), Calamos Advisors LLC (10M shares), Castle Creek Arbitrage, LLC (9.25M shares), PUTNAM INVESTMENTS LLC (8.94M shares), Mohican Financial Management, LLC (8M shares), BASSO CAPITAL MANAGEMENT L.P. (7.5M shares), and Ameriprise Financial Inc (5.3M shares).
This table shows the top 21 institutional owners of the company. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.